MVA-SARS-2-S
MVA-SARS-2-S Uses, Dosage, Side Effects, Food Interaction and all others data.
MVA-SARS-2-S is a COVID-19 vaccine candidate that contains a Modified Vaccinia Virus Ankara (MVA) vector expressing the SARS-CoV-2 spike protein. MVA is a highly attenuated poxvirus vector that has a high-level of biological safety due to its quality of being a non-replicating virus in mammalian hosts and is used to develop vaccines for infectious diseases and cancer.
Trade Name | MVA-SARS-2-S |
Generic | MVA-SARS-2-S |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here MVA-SARS-2-S